An update on pharmacological potential of boswellic acids against chronic diseases

NK Roy, D Parama, K Banik, D Bordoloi… - International journal of …, 2019 - mdpi.com
Natural compounds, in recent years, have attracted significant attention for their use in the
prevention and treatment of diverse chronic diseases as they are devoid of major toxicities …

Revisiting telomere shortening in cancer

K Okamoto, H Seimiya - Cells, 2019 - mdpi.com
Telomeres, the protective structures of chromosome ends are gradually shortened by each
cell division, eventually leading to senescence or apoptosis. Cancer cells maintain the …

H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions

Y Cai, Y Zhang, YP Loh, JQ Tng, MC Lim, Z Cao… - Nature …, 2021 - nature.com
The mechanisms underlying gene repression and silencers are poorly understood. Here we
investigate the hypothesis that H3K27me3-rich regions of the genome, defined from clusters …

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

R Liu, T Zhang, G Zhu, M Xing - Nature communications, 2018 - nature.com
The unique oncogene duet of coexisting BRAF V600E and TERT promoter mutations are
widely found to be a robust genetic background promoting human cancer aggressiveness …

Focus on formononetin: anticancer potential and molecular targets

SKL Ong, MK Shanmugam, L Fan, SE Fraser, F Arfuso… - Cancers, 2019 - mdpi.com
Formononetin, an isoflavone, is extracted from various medicinal plants and herbs, including
the red clover (Trifolium pratense) and Chinese medicinal plant Astragalus membranaceus …

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation

N Noureen, S Wu, Y Lv, J Yang, WK Alfred Yung… - Nature …, 2021 - nature.com
Active telomerase is essential for stem cells and most cancers to maintain telomeres. The
enzymatic activity of telomerase is related but not equivalent to the expression of TERT, the …

Treating cancer by targeting telomeres and telomerase

M Ivancich, Z Schrank, L Wojdyla, B Leviskas… - Antioxidants, 2017 - mdpi.com
Telomerase is expressed in more than 85% of cancer cells. Tumor cells with metastatic
potential may have a high telomerase activity, allowing cells to escape from the inhibition of …

Current insights to regulation and role of telomerase in human diseases

MB Ozturk, Y Li, V Tergaonkar - Antioxidants, 2017 - mdpi.com
The telomerase ribonucleoprotein complex has a pivotal role in regulating the proliferation
and senescence of normal somatic cells as well as cancer cells. This complex is comprised …

Phytotherapy in integrative oncology—an update of promising treatment options

AM Zimmermann-Klemd, JK Reinhardt, M Winker… - Molecules, 2022 - mdpi.com
Modern phytotherapy is part of today's conventional evidence-based medicine and the use
of phytopharmaceuticals in integrative oncology is becoming increasingly popular …

[HTML][HTML] Pathogenic TERT promoter variants in telomere diseases

F Gutierrez-Rodrigues, FS Donaires, A Pinto… - Genetics in …, 2019 - Elsevier
Purpose The acquisition of pathogenic variants in the TERT promoter (TERTp) region is a
mechanism of tumorigenesis. In nonmalignant diseases, TERTp variants have been …